MedPath

Magnesium

Generic Name
Magnesium
Brand Names
Vitafol-one
Drug Type
Small Molecule
Chemical Formula
H2Mg
CAS Number
7439-95-4
Unique Ingredient Identifier
I38ZP9992A
Background

Magnesium is classified as an alkaline earth metal and has 2 hydration shells. The element can be found in abundance in the hydrosphere and in mineral salts such as dolomite and magnesium carbonate.

Common dietary sources of magnesium include nuts (cashews, peanuts, almonds), beans, bananas, apples, carrots, broccoli, and leafy greens. Magnesium is an important enzyme cofactor and is essential to several metabolic processes. Further, the mineral helps regulate blood pressure and is necessary for RNA, DNA and protein synthesis among several other functions.

Despite the importance of magnesium and its availability via several food sources, an estimated 56 to 68% of adults who live in developed, western countries do not meet the recommended daily intake (RDI) of magnesium. Several factors and common behaviours reduce the availability of magnesium in the diet such as food processing and cooking vegetables (which are normally a rich source of magnesium).

Indication

Healthy levels of magnesium can be achieved through a well balanced diet, but if food sources are insufficient, magnesium supplements can be used to prevent and treat magnesium deficiencies.

In medicine, various magnesium salts may be used in laxative and antacid products. For example, magnesium citrate is available over-the-counter and may be used to manage occasional constipation. Magnesium sulfate may be used on its own or with total parenteral nutrition to treat hypomagnesemia. Magnesium sulfate is also indicated to prevent seizures in pregnant women with pre-eclampsia, and to manage seizures associated with eclampsia.

Associated Conditions
Calcium Deficiency, Magnesium Deficiency, Zinc Deficiency

Adjuvants for Bupivacaine in Brachial Plexus Block in Pediatrics

Not Applicable
Not yet recruiting
Conditions
Upper Limb Injury
Interventions
Drug: magnesium sulfate.
Drug: clonidine.
First Posted Date
2023-12-26
Last Posted Date
2023-12-26
Lead Sponsor
Assiut University
Target Recruit Count
70
Registration Number
NCT06180941

Effect of Adding Magnesium Sulphate in Pericapsular Nerve Group Block

Phase 2
Not yet recruiting
Conditions
Hip Fractures
Interventions
First Posted Date
2023-12-22
Last Posted Date
2023-12-22
Lead Sponsor
Assiut University
Target Recruit Count
62
Registration Number
NCT06180031
Locations
🇪🇬

Assiut University Hospital, Assiut, Egypt

Timely Administration of IV Magnesium Sulfate in Patients With a Moderate Asthma Exacerbation

Early Phase 1
Recruiting
Conditions
Asthma Attack
Asthma in Children
Interventions
Drug: Magnesium Sulfate within the first hour
Other: No Magnesium sulfate within the first hour
First Posted Date
2023-11-18
Last Posted Date
2024-12-06
Lead Sponsor
University of Oklahoma
Target Recruit Count
100
Registration Number
NCT06137040
Locations
🇺🇸

Oklahoma Children's Hospital, Oklahoma City, Oklahoma, United States

Essential 3 - Decentralized, Phase 3 Study Evaluating the Safety and Efficacy of Ulixacaltamide in Essential Tremor (ET)

Phase 3
Recruiting
Conditions
Essential Tremor
Interventions
Drug: 60 mg ulixacaltamide
Drug: Placebo
First Posted Date
2023-10-17
Last Posted Date
2024-04-05
Lead Sponsor
Praxis Precision Medicines
Target Recruit Count
600
Registration Number
NCT06087276
Locations
🇺🇸

United BioSource LLC, Morgantown, West Virginia, United States

Dexmedetomidine Versus Ketamine Versus Magnesium Sulfate for the Prevention of Emergence Agitation Following Sevoflurane Induced Anesthesia in Cardiac Catheterization in Pediatrics

Phase 1
Recruiting
Conditions
Anesthesia Emergence Delirium
Interventions
First Posted Date
2023-10-11
Last Posted Date
2023-10-11
Lead Sponsor
Cairo University
Target Recruit Count
100
Registration Number
NCT06077539
Locations
🇪🇬

Amany Hassan Saleh, Giza, Egypt

Early Parkinson's Disease Monotherapy With CVN424

Phase 2
Completed
Conditions
Parkinson's Disease
Interventions
Drug: CVN424 150 mg
Drug: Placebo
First Posted Date
2023-08-23
Last Posted Date
2025-02-26
Lead Sponsor
Cerevance Beta, Inc.
Target Recruit Count
62
Registration Number
NCT06006247
Locations
🇺🇸

University of Alabama at Birmingham, Birmingham, Alabama, United States

🇺🇸

Barrow Neurological Institute, Phoenix, Arizona, United States

🇺🇸

St Joseph's Hospital and Medical Center, Phoenix, Arizona, United States

and more 39 locations

A Study of TG103 Injection in Non-diabetic Overweight or Obesity

Phase 3
Not yet recruiting
Conditions
Overweight or Obesity
Interventions
Drug: TG103 22.5 mg
Drug: Placebo
First Posted Date
2023-08-18
Last Posted Date
2023-08-21
Lead Sponsor
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
Target Recruit Count
675
Registration Number
NCT05997576
Locations
🇨🇳

Clinical Trials Information Group, Shijiazhuang, Hebei, China

Efficacy of Magnesium Sulfate as an Adjuvant in Erector Spinae Plane Block as an Anesthetic Post Operative After Modified Radical Mastectomy

Early Phase 1
Not yet recruiting
Conditions
ESPB, Mg Sulfate,Post Mastectomy
Interventions
Drug: Magnesium sulfate in erector spinae plane block
First Posted Date
2023-08-04
Last Posted Date
2024-03-04
Lead Sponsor
Assiut University
Target Recruit Count
60
Registration Number
NCT05976464

Efficacy, Safety, and PK of M5717 in Combination With Pyronaridine as Chemoprevention in Adults and Adolescents With Asymptomatic Plasmodium Falciparum Infection (CAPTURE-2)

Phase 2
Completed
Conditions
Malaria Infection
Interventions
Drug: M5717 60 mg
Drug: Atovaquone-Proguanil
Drug: M5717 200 mg
Drug: M5717 660mg
First Posted Date
2023-08-03
Last Posted Date
2025-01-31
Lead Sponsor
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Target Recruit Count
192
Registration Number
NCT05974267
Locations
🇧🇫

Groupe de Recherche Action en Sante (GRAS), Ouagadougou 06, Burkina Faso

🇬🇲

MRC Unit The Gambia at LSHTM, Banjul, Gambia

🇰🇪

Kisumu County Referral Hospital, Kisumu, Kenya

and more 1 locations

Magnesium as an Adjuvant Agent for Postoperative Pain

Phase 4
Recruiting
Conditions
Pain, Postoperative
Interventions
Drug: IV Magnesium Sulfate
First Posted Date
2023-07-17
Last Posted Date
2025-03-19
Lead Sponsor
University Hospitals Cleveland Medical Center
Target Recruit Count
64
Registration Number
NCT05947760
Locations
🇺🇸

University Hospitals, Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath